Clinical Overview

Left atrial enlargement (LAE) is an anatomic/echocardiographic diagnosis: an abnormal increase in left atrial size, typically from prolonged elevation of left atrial pressure or volume rather than a primary disease of the chamber itself (Left Atrial Enlargement, StatPearls, Parajuli, Alahmadi & Ahmed, updated January 2025). “Enlargement” and “hypertrophy” describe two conceptually different structural changes — a stretched, dilated cavity versus a thickened muscular wall — and the reference echocardiographic standard for LAE, left atrial volume index (LAVi, indexed to body surface area), is specifically a chamber-size measure, not a wall-thickness measure (Left Atrial Enlargement, StatPearls, 2025). In practice, though, the clinical literature does not keep these two concepts cleanly separated: LITFL’s overview of LAE groups “enlargement” and “hypertrophy” together as alternate names for this finding (Left Atrial Enlargement, LITFL, 2024), and because a surface ECG cannot tell a thickened wall from a dilated cavity apart, the 2009 AHA/ACCF/HRS scientific statement on ECG standardization recommends “atrial abnormality” as the more accurate umbrella term for the P-wave pattern both produce, rather than “enlargement,” “hypertrophy,” “overload,” or “P mitrale” (Hancock et al., Circulation, 2009). This page covers LAE as this dataset’s label for that P-wave pattern; this dataset’s separate Left Atrial Hypertrophy (LAH) label uses the identical ECG criteria, and in this dataset’s record labels the two are applied as mutually exclusive tags — no record carries both — reflecting the interpreting clinician’s original term choice rather than a distinguishable ECG feature. LAE is also a much rarer label in this dataset than LAH, so most of this dataset’s left-atrial-pressure-load findings were read and recorded as LAH rather than LAE. A strip carrying this dataset’s LAE label is asserting a P-wave pattern historically read as suggesting an enlarged left atrium, not a confirmed volumetric finding on imaging.

Mechanistically, the P wave’s first half reflects right atrial depolarization and its second half reflects left atrial depolarization, which starts slightly later (P Wave, StatPearls, Douedi & Douedi). Sustained pressure or volume overload drives structural, functional, and electrical remodeling of the left atrium: interstitial fibrosis promoted by angiotensin II, transforming growth factor-beta, and platelet-derived growth factor stretches and stiffens the chamber, lengthening the time the delayed left atrial component takes to complete — which widens and often notches the P wave in lead II and produces a widened, deepened terminal negative deflection in V1 (Left Atrial Enlargement, StatPearls, 2025; P Wave, StatPearls). The same remodeling process shortens atrial refractory periods, alters ion channel function, and disrupts gap-junction coupling in ways that facilitate reentry, which is why LAE and atrial fibrillation reinforce each other rather than one simply causing the other (Left Atrial Enlargement, StatPearls, 2025). In the absence of mitral valve disease, atrial fibrillation, or a high-cardiac-output state, LAE is considered a reliable marker of underlying left ventricular diastolic dysfunction — the chamber enlarges because it is chronically working against a stiffer, less compliant left ventricle (Left Atrial Enlargement, StatPearls, 2025). Not every cause is pathologic: LAE is also described in trained athletes as a physiologic adaptation to sustained volume load, occurring in roughly one in five competitive athletes without indicating disease (Left Atrial Enlargement, StatPearls, 2025).

The P-wave pattern associated with LAE correlates only imperfectly with true anatomic enlargement confirmed on imaging, even at its best-performing criterion. A 2025 study of 1,000 patients comparing ECG criteria against echocardiography and cardiac MRI found that a lead II P-wave duration of 120 ms or more — a stricter, different cutoff than the >110 ms screening threshold used elsewhere on this page — had the strongest single-criterion correlation with imaging (area under the curve of 0.81) among the criteria tested, and concluded that ECG criteria for left atrial enlargement correlated only poorly with both echocardiography and cardiac MRI overall, and that current criteria need revisiting (Puthenpura et al., “Correlating Left Atrial Enlargement and Left Ventricular Hypertrophy on ECG With Echocardiography and Cardiac Magnetic Resonance Imaging,” Journal of the American Heart Association, 2025). In practice this means the P-wave pattern is a reasonable prompt to investigate further, but it should not be treated as confirming or excluding true left atrial enlargement without echocardiographic correlation (2025 study, above).

LAE is often asymptomatic and discovered incidentally on ECG or echocardiogram (Left Atrial Enlargement, StatPearls, 2025). When symptoms occur, they most often come from the underlying condition driving the left atrial load or from an arrhythmia the enlarged chamber has helped sustain: exertional dyspnea or orthopnea, fatigue, palpitations, chest discomfort, cough from pulmonary congestion, peripheral edema, and syncope or dizziness are described, along with stroke or transient ischemic attack from thromboembolism in more advanced disease (Left Atrial Enlargement, StatPearls, 2025). A markedly enlarged left atrium can also compress adjacent structures, producing hoarseness from left recurrent laryngeal nerve compression (a pattern known as Ortner syndrome) (Ortner’s syndrome, Wikipedia) or dysphagia from esophageal compression, though these are uncommon and reflect substantial chamber enlargement rather than an early or mild finding (Left Atrial Enlargement, StatPearls, 2025).

Left ventricular diastolic dysfunction is the driver most directly linked to LAE when other causes are excluded, and systemic hypertension, obesity, aortic stenosis, and mitral valve disease (stenosis or regurgitation) are also well-established causes (Left Atrial Enlargement, StatPearls, 2025). Isolated mitral stenosis is the classic example of a comparatively pure pressure-overload cause: the narrowed valve raises left atrial pressure and forces the chamber to enlarge against that load, while the left ventricle, starved of the inflow it would need to hypertrophy, experiences impaired diastolic filling instead (Mitral Stenosis, StatPearls, Alahmadi, Haleem & Sharma). Rising body-mass-index burden accumulated from childhood through middle age is independently associated with longer P-wave duration and larger left atrial size, identifying sustained excess weight — not just adult-onset hypertension — as a meaningful, modifiable contributor (Istolahti et al., “Early life and adulthood risk factors for middle age P-wave prolongation and left atrial enlargement,” European Journal of Preventive Cardiology, 2026). Obstructive sleep apnea is a further recognized cause: the repetitive negative intrathoracic pressure swings during apneic events repeatedly stretch the left atrium over time (Left atrial enlargement, Wikipedia). Chronic atrial fibrillation is both a cause and a consequence, and rarer causes include atrial myxoma, arteriovenous fistula, and left-to-right shunting lesions such as a ventricular septal defect or patent ductus arteriosus (Left Atrial Enlargement, StatPearls, 2025).

Interpretation Guide

Key Features:

• Rate: not a defining feature — LAE is a chamber finding whose ECG correlate can appear at any underlying rate
• Rhythm: not a defining feature — the finding describes left atrial size, not rhythm origin, though it is a recognized substrate for atrial fibrillation; if atrial fibrillation is already present, no discrete P wave appears on the strip and the duration/morphology criteria below cannot be assessed at all (Left atrial enlargement, Wikipedia)
• P waves: the ECG correlate is a widened P wave — total duration exceeding 110 ms in any lead is the general screening threshold, with the classic “P mitrale” pattern being a notched, bifid P wave in lead II with an interpeak interval exceeding 40 ms, plus a widened (>40 ms) and deepened (>1 mm) terminal negative deflection in V1; a leftward-shifted P-wave axis (<30°) is also described; P-wave amplitude stays within the normal range (Left Atrial Enlargement, StatPearls, 2025; Left Atrial Enlargement, LITFL, 2024)
• PR interval: within normal limits (0.12-0.20 s) unless a separate, coexisting conduction disturbance is present
• QRS complex: within normal limits unless left ventricular hypertrophy or another coexisting abnormality is also present — left ventricular hypertrophy voltage criteria often accompany this finding given their shared underlying causes, but an isolated pressure-overload cause like mitral stenosis, or a physiologic cause like athletic conditioning, can produce this P-wave finding with the left ventricle staying normal (Mitral Stenosis, StatPearls; Left Atrial Enlargement, StatPearls, 2025)
• ST segment: within normal limits; not a defining feature of this finding on its own
• T waves: within normal limits; not a defining feature of this finding on its own
• QT interval: within normal limits; not a defining feature of this finding
• Other findings: confirm the rhythm is not already atrial fibrillation before applying any P-wave duration criterion, since no discrete P wave is present to measure once fibrillation is established; even the best-performing single ECG criterion for this finding correlates only imperfectly with true anatomic enlargement on echocardiography or cardiac MRI, so echocardiographic correlation — specifically left atrial volume index — is what actually establishes or excludes the diagnosis, not the strip alone (2025 correlation study, cited above)

The defining ECG correlate, at any cause, is duration without amplitude: this is the same P-wave criterion used for P mitrale and for this dataset’s separate LAH label, so the strip cannot distinguish among the three — only echocardiography can confirm which anatomic finding, if any, is actually present.

Key Leads

• Lead II – Primary lead for the associated P-wave finding; the duration criterion (>110 ms) and notched/bifid “P mitrale” morphology are assessed here, and this is the lead where a stricter P-wave duration cutoff (≥120 ms) best correlates with imaging-confirmed enlargement among the standard criteria, even though the correlation remains imperfect overall (2025 correlation study, cited above)
• Lead V1 – Assesses the P wave’s terminal, left-atrial component; a widened and deepened terminal negative deflection supports the same finding, though this criterion correlates with imaging-confirmed enlargement more weakly than the lead II duration criterion does (2025 correlation study, cited above)

Differential Diagnosis

• Left Atrial Hypertrophy (LAH) — this dataset’s separate label sharing the identical P-wave duration criteria; in this dataset’s records the two labels are mutually exclusive (no record carries both), which reflects the original reading clinician’s label choice rather than a distinguishable ECG feature, since only echocardiography can separate a dilated chamber from a thickened wall
• Prolonged P Wave (PPW) — this dataset’s label for the ECG sign itself (P mitrale); LAE is one of the anatomic findings this sign is presumed to indicate, but the two are not the same kind of claim — PPW describes the observed waveform, while LAE asserts a presumed underlying chamber-size finding
• Left Ventricle Hypertrophy (LVH) — the companion ventricular finding, driven by the same pressure-overload states (hypertension, mitral and aortic valve disease) that produce LAE; distinguishing clue: LVH requires its own QRS voltage and axis criteria, which an isolated P-wave finding does not meet, and pure atrial-pressure-overload causes like mitral stenosis can produce LAE without it
• Right Atrial Hypertrophy (RAH) — a different chamber’s finding built on amplitude rather than duration criteria (a tall, peaked P wave in the inferior leads, not a widened, notched one); height versus duration is the discriminator, and the two can coexist when disease affects both atria together
• P Wave Change (PWC) — this dataset’s broader catch-all label for any altered P-wave morphology, including flattening, notching, or biphasic change; a PWC label does not by itself indicate the duration increase that specifically anchors LAE’s P-wave criterion

Treatment Brief

Left atrial enlargement itself has no guideline-based, direct treatment — no known medical therapy has been shown to reverse left atrial remodeling — so management targets whatever is driving the underlying pressure or volume load (Left Atrial Enlargement, StatPearls, 2025).

• Confirm the rhythm is not already atrial fibrillation before evaluating a P-wave duration finding — fibrillation removes the discrete P wave the criteria depend on — and confirm lead placement and calibration before accepting a duration measurement.
• Compare against a prior ECG when available — a longstanding, unchanged pattern in an asymptomatic patient is reassuring, while a new one warrants further evaluation.
• Correlate clinically, and with echocardiography when the finding is new or otherwise unexplained, rather than treating the ECG pattern as confirmation of true left atrial enlargement — even its best-performing criterion correlates only imperfectly with imaging, so a normal-appearing P wave does not exclude it either.
• Evaluate for an underlying driver: assessment for diastolic dysfunction and heart failure, blood pressure control and hypertension workup, mitral and aortic valve evaluation, weight and sleep-apnea history, and review of atrial fibrillation history, since the two conditions reinforce each other over time.
• Watch for and report new atrial arrhythmias — LAE is a recognized substrate for atrial fibrillation, and established atrial fibrillation is itself managed with stroke-risk-based anticoagulation once identified.
• Note the clinical context: a comparable finding in a young, asymptomatic competitive athlete more often reflects benign physiologic remodeling than it does in an older patient with hypertension or valve disease, and in this dataset LAE is a far rarer label than the companion LAH label, worth keeping in mind when weighing how representative any single matching record is.